CNS lupus: A study of 41 patients

Neurology

Volumn 69, Issue 7, 2007, Pages 644-654

  Joseph, Fady G ^a   Lammie, G Alistair ^b   Scolding, Neil J ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DOSULEPIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; STEROID; WARFARIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMORY DISORDER; MONOTHERAPY; MOTOR DYSFUNCTION; MYOCLONUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PLASMA VISCOSITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34547903909     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000267320.48939.d0     Document Type: Article

References (75)

1. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50.
2. Molokhia M, McKeigue PM, Cuadrado M, Hughes G. Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK. Lancet 2001;357:1414-1415.
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-.
4. Hebra F, Kaposi M. On diseases of the skin, including exanthema. New Sydenham Society, London. 1875;4:1-247.
5. Osler W. On the visceral complications of erythema exudativum multiforme. Am J Med Sci 1895;110:629-646.
6. McCune WJ, Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am 1988;14:149-167.
7. van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 1991;11:1-11.
8. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30:985-992.
9. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323-339.
10. Dubois EL, Tuffanelli DL. Clinical Manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964;190:104-111.
11. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
12. Cha JH, Furie K, Kay J, Walensky RP, Mullins ME, Hedley-Whyte ET. Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness. N Engl J Med 2006;355:2678-2689.
13. Mikdashi J, Krumholz A, Handwerger B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 2005;64:2102-2107.
14. Toubi E, Khamashta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995;99:397-401.
15. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-1220.
16. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003;61:108-110.
17. Costallat L, Bertolo M, Appenzeller S. The American College of Rheumatology (ACR) nomenclature and case definitions for neuropsychiatric lupus syndromes. Analysis of 527 patients. Lupus 2001;10.
18. Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002;41:1308-1312.
19. Parikh S, Swaiman KF, Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995;13:198-201.
20. Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536-1542.
21. Loh WF, Hussain IM, Soffiah A, Lim YN. Neurological manifestations of children with systemic lupus erythematosus. Med J Malaysia 2000;55:459-463.
22. Quintero-Del-Rio AI, Van M. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol 2000;15:803-807.
23. Harel L, Sandborg C, Lee T, von Scheven E. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 2006;33:1873-1877.
24. Baca V, Lavalle C, Garcia R, et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 1999;26:432-439.
25. Steinlin MI, Blaser SI, Gilday DL, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995;13:191-197.
26. Reiff A, Miller J, Shaham B, Bernstein B, Szer IS. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography. J Rheumatol 1997;24:2461-2465.
27. Janavs JL, Aminoff MJ. Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 1998;65:436-445.
28. Guttman M, Lang AE, Garnett ES, et al. Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea. Mov Disord 1987;2:201-210.
29. Aarli JA. Immunological aspects of epilepsy. Brain Dev 1993;15:41-49.
30. Feinfeld DA, Scholnick HR, Janis R. Lupus nephritis in a neuronal storage disease. Arch Intern Med 1977;137:693-694.
31. Noto M, Kato M, Takeda R, Izaki K, Kitagawa M. [Case of systemic lupus erythematosus (SLE) with giant cell arteritis of the brain causing akinetic mutism and myclonus]. Rinsho Shinkeigaku 1975;15:743-751.
32. Miyoshi Y, Atsumi T, Kitagawa H, et al. Parkinsonlike symptoms as a manifestation of systemic lupus erythematosus. Lupus 1993;2:199-201.
33. Osawa H, Yamabe H, Kaizuka M, et al. Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms. Lupus 1997;6:613-615.
34. Shahar E, Goshen E, Tauber Z, Lahat E. Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol 1998;18:456-458.
35. Garcia-Moreno JM, Chacon J. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. Mov Disord 2002;17:1329-1335.
36. Kwong KL, Chu R, Wong SN. Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus. Lupus 2000;9:474-477.
37. Tan EK, Chan LL, Auchus AP. Reversible parkinsonism in systemic lupus erythematosus. J Neurol Sci 2001;193:53-57.
38. Chacon J, Garcia-Moreno JM, Valencia J, et al. [Parkinson disease of juvenile onset with systemic lupus erythematosus in a pre-symptomatic stage]. Rev Neurol 1999;29:725-727.
39. Lim SM, Oldfield M, Abbott RJ. Systemic lupus erythematosus presenting with steroid-responsive parkinsonism and post-hemiplegic dystonia. Eur J Neurol 1998;5:309-312.
40. Fabiani G, Teive HA, Germiniani FM, Sa DS, Werneck LC. Reversible parkinsonian syndrome in systemic and brain vasculitis. Mov Disord 2002;17:601-604.
41. Kunas RC, McRae A, Kesselring J, Villiger PM. Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease. J Allergy Clin Immunol 1995;96:688-690.
42. Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 1981;24:1389-1395.
43. Willoughby EO, Cardon L, Rubnitz ME. Clinicopathologic conference: psychotic episodes, meningitis and chest pain. Postgrad Med 1964;35:318-326.
44. Nagaoka S, Kato K, Ishigatsubo Y, et al. [A case of systemic lupus erythematosus with akinesia, muscle rigidity and neurogenic bladder]. Ryumachi 1984;24:382-388.
45. Poch G. Enfermedades del colageno. Manifestaciones neurologicas, musculares y psiquiatricas. Buenos Aires: Lopez Libreros Editores SRL, 1960.
46. Seminario C, Pessano J. Cuatro casos clinicos de lupus eritematoso agudo. Sem Med (B Air) 1930;2:721-730.
47. Morales-Buenrostro LE, Tellez-Zenteno JF, Estanol B. [Symptomatic hemiparkinsonism with abnormal SPECT in a patient with systemic lupus erythematosus (SLE)]. Neurologia 2002;17:391-393.
48. Tola MR, Granieri E, Caniatti L, et al. Systemic lupus erythematosus presenting with neurological disorders. J Neurol 1992;239:61-64.
49. Venegoni E, Biasioli R, Lamperti E, Rinaldi E, Salmaggi A, Novi C. Tremor as an early manifestation of systemic lupus erythematosus. Clin Exp Rheumatol 1994;12:199-201.
50. Dennis MS, Byrne EJ, Hopkinson N, Bendall P. Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. J Neurol Neurosurg Psychiatry 1992;55:1157-1161.
51. Kammer GM, Mishra N. Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am 2000;26:475-492.
52. Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol 2002;28:173-189.
53. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000;9:498-503.
54. Markus HS, Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol 1992;239:39-42.
55. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496-500.
56. Hanly JG, Liang MH. Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues. Ann NY Acad Sci 1997;823:60-68.
57. Wekking EM. Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosom Med 1993;55:219-228.
58. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-124.
59. Chandrasekaran AN, Rajendran CP, Ramakrishnan S, Madhavan R, Parthiban M. Childhood systemic lupus erythematosus in south India. Indian J Pediatr 1994;61:223-229.
60. Keane JR. Eye movement abnormalities in systemic lupus erythematosus. Arch Neurol 1995;52:1145-1149.
61. Peponis V, Kyttaris VC, Tyradellis C, Vergados I, Sitaras NM. Ocular manifestations of systemic lupus erythematosus: a clinical review. Lupus 2006;15:3-12.
62. Yap EY, Au Eong KG, Fong KY, et al. Ophthalmic manifestations in Asian patients with systemic lupus erythematosus. Singapore Med J 1998;39:557-559.
63. Al-Mayouf SM, Al-Hemidan AI. Ocular manifestations of systemic lupus erythematosus in children. Saudi Med J 2003;24:964-966.
64. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576-583.
65. Escalante A, Brey RL, Mitchell BD Jr, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995;98:559-565.
66. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival. J Rheumatol 1993;20:1684-1693.
67. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995;99:153-163.
68. McLean BN, Miller D, Thompson EJ. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 1995;58:548-554.
69. Zanardi VA, Magna LA, Costallat LT. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE). Clin Rheumatol 2001;20:245-250.
70. Glanz BI, Laoprasert P, Schur PH, Robertson-Thompson A, Khoshbin S. Lateralized EEG findings in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Clin Electroencephalogr 2001;32:14-19.
71. Fulford KW, Catterall RD, Delhanty JJ, Doniach D, Kremer M. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain 1972;95:373-386.
72. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-221.
73. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47:337-369.
74. Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med 2000;93:169-174.
75. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 1993;2:303-312.